Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: In vivo study with gene-deleted mice

[1]  N. Krug,et al.  Pituitary adenylate cyclase‐activating peptide receptor 1 mediates anti‐inflammatory effects in allergic airway inflammation in mice , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  A. Tamas,et al.  Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury , 2011, Neuropeptides.

[3]  D. Reglodi,et al.  Comparison of Intestinal Warm Ischemic Injury in PACAP Knockout and Wild-Type Mice , 2010, Journal of Molecular Neuroscience.

[4]  H. Vaudry,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery , 2009, Pharmacological Reviews.

[5]  P. Emson,et al.  Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice , 2009, Proceedings of the National Academy of Sciences.

[6]  J. Behr,et al.  Inhalation of vasoactive intestinal peptide in pulmonary hypertension , 2008, European Respiratory Journal.

[7]  K. Nagai,et al.  Lack of light-induced elevation of renal sympathetic nerve activity and plasma corticosterone levels in PACAP-deficient mice , 2008, Neuroscience Letters.

[8]  T. Martin,et al.  Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.

[9]  J. Braun,et al.  Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP , 2007, International journal of cancer.

[10]  G. Toth,et al.  Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat , 2007, Peptides.

[11]  E. Pintér,et al.  Role of capsaicin-sensitive afferents and sensory neuropeptides in endotoxin-induced airway inflammation and consequent bronchial hyperreactivity in the mouse , 2007, Regulatory Peptides.

[12]  E. Pintér,et al.  Role of transient receptor potential vanilloid 1 receptors in endotoxin-induced airway inflammation in the mouse. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[13]  E. Pintér,et al.  Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice , 2006, Neuroscience.

[14]  J. Waschek,et al.  Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[15]  A. Lindén,et al.  Long-lasting smooth-muscle relaxation by a novel PACAP analogue in human bronchi , 2004, Regulatory Peptides.

[16]  Shijie Jin,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells , 2004, Multiple sclerosis.

[17]  D. Reglodi,et al.  Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. , 2004, Current pharmaceutical design.

[18]  S. Onoue,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells. , 2004, European journal of biochemistry.

[19]  R. Dérand,et al.  Activation of VPAC1 receptors by VIP and PACAP‐27 in human bronchial epithelial cells induces CFTR‐dependent chloride secretion , 2004, British journal of pharmacology.

[20]  T. Sugimoto,et al.  Pituitary adenylate cyclase-activating polypeptide-immunoreactive nerve fibers in rat and human tooth pulps , 2003, Brain Research.

[21]  J. Kinhult,et al.  Pituitary adenylate cyclase‐activating polypeptide, effects in the human nose , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  B. Ekstrand-Hammarström,et al.  Vitamin E reduces transendothelial migration of neutrophils and prevents lung injury in endotoxin-induced airway inflammation. , 2003, American journal of respiratory cell and molecular biology.

[23]  D. Schwartz,et al.  Neutrophils play a critical role in development of LPS-induced airway disease. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[24]  J. Bates,et al.  A reevaluation of the validity of unrestrained plethysmography in mice. , 2002, Journal of applied physiology.

[25]  S. Shioda,et al.  PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. , 2002, Current protein & peptide science.

[26]  M. Delgado,et al.  Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[27]  J. Miyazaki,et al.  Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Rabe,et al.  The effect of the vasoactive intestinal polypeptide agonist Ro 25–1553 on induced tone in isolated human airways and pulmonary artery , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[29]  D. Schwartz,et al.  Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. , 2001, American journal of respiratory cell and molecular biology.

[30]  M. Delgado,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Collagen-Induced Arthritis: An Experimental Immunomodulatory Therapy1 , 2001, The Journal of Immunology.

[31]  E. Varricchio,et al.  Pituitary adenylate cyclase activating peptide (PACAP) immunoreactivity in the ureter of the duck , 2001, Cell and Tissue Research.

[32]  A. Kraneveld,et al.  Tachykinins and neuro-immune interactions in asthma. , 2001, International immunopharmacology.

[33]  B. Vargaftig,et al.  Airway administration of Escherichia coli endotoxin to mice induces glucocorticosteroid-resistant bronchoconstriction and vasopermeation. , 2001, American journal of respiratory cell and molecular biology.

[34]  J. Hardwick,et al.  Pituitary adenylate cyclase-activating polypeptide innervation of the mudpuppy cardiac ganglion , 2000, Brain Research.

[35]  G. Bodega,et al.  Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung☆ , 2000, Peptides.

[36]  D. Rogers,et al.  Effect of vasoactive intestinal peptide (VIP)‐related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro , 1999, British journal of pharmacology.

[37]  J. Hannibal,et al.  Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland , 1999, Cell and Tissue Research.

[38]  J. Nadel,et al.  Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides. , 1999, The European respiratory journal.

[39]  J. Hannibal,et al.  Innervation of the rat pineal gland by pituitary adenylate cyclase-activating polypeptide (PACAP)-immunoreactive nerve fibres , 1999, Cell and Tissue Research.

[40]  E. Muñoz-Elías,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. , 1999, Journal of immunology.

[41]  J. Hannibal,et al.  PACAP in Visceral Afferent Nerves Supplying the Rat Digestive and Urinary Tracts a , 1998, Annals of the New York Academy of Sciences.

[42]  D. Leduc,et al.  Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. , 1998, Journal of immunology.

[43]  B. Tackenberg,et al.  Effects of VIP and Related Peptides on Airway Mucus Secretion from Isolated Rat Trachea , 1998, Peptides.

[44]  J. Hannibal,et al.  Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract , 1998, Neuroscience.

[45]  L. Pei.  Genomic structure and embryonic expression of the rat type 1 vasoactive intestinal polypeptide receptor gene , 1997, Regulatory Peptides.

[46]  J. Nadel,et al.  Long lasting smooth muscle relaxation by a novel PACAP analogue in guinea‐pig and primate airways in vitro , 1997, British journal of pharmacology.

[47]  J. Hannibal,et al.  Immunocytochemical demonstration of pituitary adenylate cyclase activating polypeptide (PACAP) in the porcine epiphyseal cartilage canals , 1997, Neuropeptides.

[48]  R. Uddman,et al.  The induction of nitric oxide‐mediated relaxation of human isolated pulmonary arteries by PACAP , 1997, British journal of pharmacology.

[49]  R. V. Sharma,et al.  Molecular Cloning of a Novel Variant of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Receptor That Stimulates Calcium Influx by Activation of L-type Calcium Channels* , 1996, The Journal of Biological Chemistry.

[50]  R. Håkanson,et al.  The contribution of nitric oxide to endotoxin‐induced ocular inflammation: interaction with sensory nerve fibres , 1996, British journal of pharmacology.

[51]  R. Håkanson,et al.  Distribution and effects of pituitary adenylate cyclase-activating peptide in the rabbit eye , 1995, Neuroscience.

[52]  S. St.-Pierre,et al.  Relaxant effects of pituitary adenylate cyclase activating polypeptide (PACAP) on epithelium-intact and -denuded guinea-pig trachea: a comparison with vasoactive intestinal peptide (VIP) , 1995, Neuropeptides.

[53]  N. Aiyar,et al.  Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. , 1995, Biochemical and biophysical research communications.

[54]  E. Goetzl,et al.  Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Bonner,et al.  Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. , 1994, Endocrinology.

[56]  F. Sundler,et al.  Pituitary adenylate cyclase activating polypeptide expression in sensory neurons , 1994, Neuroscience.

[57]  R. Garippa,et al.  Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis. , 1994, The Journal of pharmacology and experimental therapeutics.

[58]  K. Forsberg,et al.  Quantification of nasal involvement in a guinea pig plethysmograph. , 1994, Journal of applied physiology.

[59]  F. Sundler,et al.  Pituitary adenylate cyclase activating peptide produces a marked and long-lasting depression of a C-fibre-evoked flexion reflex , 1993, Neuroscience.

[60]  F. Sundler,et al.  Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: Immunocytochemical and immunochemical evidence , 1993, Neuroscience.

[61]  J. Warren,et al.  Opposing roles of cyclic AMP in the vascular control of edema formation , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  A. Arimura,et al.  Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). , 1993, Biochemical and biophysical research communications.

[63]  K. Takagi,et al.  Relaxant effect of pituitary adenylate cyclase-activating polypeptide on guinea-pig tracheal smooth muscle. , 1992, European journal of pharmacology.

[64]  R. Shigemoto,et al.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.

[65]  R. Rylander,et al.  Endotoxins and the lung: cellular reactions and risk for disease. , 1983, Progress in allergy.

[66]  J. Szolcsányi,et al.  Role of transient receptor potential vanilloid 1 receptors in endotoxin-induced airway inflammation in the mouse. Am J Physiol Lung Cell Mol Physiol 292:L1173-L1181 , 2007 .

[67]  J. Waschek,et al.  Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. , 2006, Current topics in medicinal chemistry.

[68]  K. Gohil,et al.  Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[69]  O. Moss,et al.  Pulmonary function assessment by whole-body plethysmography in restrained versus unrestrained mice. , 2002, Journal of pharmacological and toxicological methods.

[70]  J. Hannibal,et al.  Pituitary adenylate cyclase-activating polypeptide in intrinsic and extrinsic nerves of the rat pancreas , 1999, Cell and Tissue Research.

[71]  D. Bolin,et al.  Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma , 1995, Biopolymers.